ZARR — ABBV

THU 05 NOV
14:34 Investing.com - UK AbbVie stock hits all-time high at 298.74 USD 49 items
11:00 [DATA] GuruFocus Sector Trends: Technology Leads, Consumer Defensive Sold on Nov. 3 2 items
WED 04 NOV
22:12 [DATA] GuruFocus AbbVie Inc (ABBV) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 77/100 2 items
18:59 [DATA] GuruFocus Nxera Pharma (SOLTF) Secures $1.5B Licensing Deal with AbbVie for IBD Therapy
14:42 Investing.com - news Freedom Broker raises Abbvie stock price target on strong results 3 items
11:06 [DATA] GuruFocus What iShares Core High Dividend (HDV) Bought: Exxon Leads on Nov. 2
11:06 [DATA] GuruFocus Capital Group Cons. Equity (CGCV) Adds Microsoft and Philip Morris on Monday
11:05 [DATA] GuruFocus State Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 2 2 items · also GuruFocus
05:05 [DATA] GuruFocus ABBV SWOT Analysis: Key Insights from 10-Q Filing 2 items
00:12 Investing.com - news AbbVie expands Oxford R&D facility as part of £120 million-plus investment
TUE 03 NOV CLOSE 286.00 -1.0% VOL 1.0×
21:30 [DATA] GuruFocus AbbVie Director Jennifer L. Davis Resigns Following CEO Appointment at Align Technology
18:43 [FILING] 10-Q sec.gov
MON 02 NOV CLOSE 288.84 -2.1% VOL 1.7×
22:00 [DATA] GuruFocus ABBV Maintained by UBS -- Price Target Raised to $295 2 items · also GuruFocus
21:05 [FILING] 8-K — FORM 8-K (Item 5.02) sec.gov
20:32 [DATA] GuruFocus ABBV Maintains Outperform Rating -- Price Target Raised to $342 4 items · also GuruFocus
18:01 [DATA] GuruFocus ABBV Maintained by Morgan Stanley -- Price Target Raised to $346 5 items
17:49 [DATA] GuruFocus AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition
14:37 [DATA] GuruFocus ABBV Maintained by Wells Fargo -- Price Target Raised to $340 3 items
11:30 [DATA] GuruFocus Company Guidance Roundup: AbbVie, Dauch Raise Outlooks on Oct. 30 2 items · also GuruFocus
11:04 [DATA] GuruFocus What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 29
FRI 30 OCT CLOSE 294.89 +1.4% VOL 1.3×
11:51 [FILING] 8-K (Item 2.02,9.01) sec.gov
THU 29 OCT CLOSE 290.79 +1.7% VOL 0.8×
WED 28 OCT CLOSE 285.99 -0.1% VOL 0.6×
TUE 27 OCT CLOSE 286.39 -0.1% VOL 0.6×
MON 26 OCT CLOSE 286.74 +0.4% VOL 0.9×
FRI 23 OCT CLOSE 285.64 +0.2% VOL 0.9×
22:04 [FILING] 3 sec.gov
THU 22 OCT CLOSE 285.19 +0.1% VOL 1.2×
WED 21 OCT CLOSE 284.80 -1.5% VOL 0.9×
TUE 20 OCT CLOSE 289.08 +2.3% VOL 1.1×
MON 19 OCT CLOSE 282.68 -1.0% VOL 0.9×
FRI 16 OCT CLOSE 285.42 +0.7% VOL 1.2×
THU 15 OCT CLOSE 283.40 -0.0% VOL 1.6×
21:00 [FILING] 8-K — FORM 8-K (Item 5.02) sec.gov
WED 14 OCT CLOSE 283.48 +3.3% VOL 1.2×
TUE 13 OCT CLOSE 274.36 -2.4% VOL 1.4×
MON 12 OCT CLOSE 281.12 +1.7% VOL 1.2×
FRI 09 OCT CLOSE 276.47 +1.5% VOL 0.9×
THU 08 OCT CLOSE 272.42 +0.4% VOL 1.2×
WED 07 OCT CLOSE 271.36 +1.8% VOL 1.4×
TUE 06 OCT CLOSE 266.69 +0.3% VOL 1.0×
MON 05 OCT CLOSE 265.76 +1.1% VOL 1.8×
21:07 [FILING] 8-K (Item 2.02,9.01) sec.gov
FRI 02 OCT CLOSE 262.82 +1.1% VOL 1.4×
22:00 [FILING] 4 sec.gov
22:00 [FILING] 4 sec.gov
THU 01 OCT CLOSE 259.93 -0.6% VOL 0.9×
WED 30 SEPT CLOSE 261.59 -0.6% VOL 1.1×
TUE 29 SEPT CLOSE 263.29 -1.1% VOL 1.0×
MON 28 SEPT CLOSE 266.28 +0.7% VOL 1.1×
FRI 25 SEPT CLOSE 264.34 -0.3% VOL 0.6×